Zhejiang Huahai Pharmaceutical Co., Ltd. (SHA:600521)
China · Delayed Price · Currency is CNY 15.89
-0.31 (-1.91%)
Oct 29, 2026, 2:35 PM CST
SHA:600521 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 8,984 | 8,587 | 9,547 | 8,309 | 8,266 | 6,644 |
Revenue Growth | 0.54% | -10.06% | 14.91% | 0.52% | 24.42% | 2.44% |
Gross Profit Gross Profit Growth | 5,045 | 5,000 | 5,809 | 4,933 | 5,086 | 3,973 |
Operating Income Operating Income Growth | 774.91 | 615.32 | 1,618 | 1,360 | 1,578 | 502.48 |
Net Income Net Income Growth | 627.82 | 266.4 | 1,119 | 830.47 | 1,168 | 487.54 |
Earnings Per Share EPS Growth | 0.42 | 0.18 | 0.77 | 0.57 | 0.80 | 0.34 |
EPS Growth | -21.07% | -76.62% | 35.09% | -28.75% | 135.29% | -46.88% |
Fiscal Year | TTM | FY 2025 | FY 2024 |
|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 |
Sales of Drug Product Sales of Drug Product Growth | 5,004 | 5,001 | 5,759 |
Technical Services Technical Services Growth | 34.91 | 44.9 | 62.88 |
Others Others Growth | 71.12 | 69.75 | 77.69 |
Sales of Raw Materials and Intermediates Sales of Raw Materials and Intermediates Growth | - | 3,469 | 3,646 |
Total Total Growth | 8,982 | 8,585 | 9,546 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 1,962 | 1,580 | 1,597 | 1,435 | 1,508 | 1,877 |
Total Debt Total Debt Growth | 8,206 | 8,038 | 7,478 | 6,858 | 6,782 | 5,523 |
Net Cash (Debt) Net Cash Growth | -6,244 | -6,457 | -5,881 | -5,422 | -5,273 | -3,646 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -4.18 | -4.36 | -4.05 | -3.72 | -3.61 | -2.54 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 1,959 | 1,230 | 2,173 | 2,217 | 1,243 | 938.43 |
Capital Expenditures CapEx Growth | -1,918 | -1,966 | -1,853 | -1,592 | -2,316 | -2,434 |
Free Cash Flow Free Cash Flow Growth | 40.26 | -735.96 | 319.33 | 624.63 | -1,074 | -1,496 |
Free Cash Flow Growth | - | - | -48.88% | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 56.16% | 58.23% | 60.85% | 59.37% | 61.53% | 59.80% |
Operating Margin | 8.63% | 7.17% | 16.95% | 16.37% | 19.09% | 7.56% |
Pretax Margin | 8.94% | 5.17% | 15.33% | 13.24% | 18.25% | 11.84% |
Profit Margin | 6.99% | 3.10% | 11.72% | 9.99% | 14.13% | 7.34% |
FCF Margin | 0.45% | -8.57% | 3.35% | 7.52% | -12.99% | -22.52% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.100 | 0.100 | 0.250 | 0.200 | 0.240 | 0.100 |
Dividend Per Share Growth | -60.00% | -60.00% | 25.00% | -16.67% | 140.00% | -50.00% |
Dividend Yield | 0.63% | 0.59% | 1.40% | 1.36% | 1.09% | 0.46% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 37.81 | 94.93 | 23.14 | 26.00 | 27.77 | 66.14 |
Forward PE | 17.61 | 13.58 | 17.02 | 15.44 | 24.43 | 20.78 |
P/FCF Ratio | 599.65 | - | 81.09 | 34.57 | - | - |
PS Ratio | 2.69 | 2.95 | 2.71 | 2.60 | 3.92 | 4.85 |